IRIS PubliCatt

Grieco, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.779
NA - Nord America 6.095
AS - Asia 1.606
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 26
AF - Africa 23
SA - Sud America 17
Totale 14.575
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.064
DE - Germania 2.834
SE - Svezia 1.304
CN - Cina 974
UA - Ucraina 692
IT - Italia 587
IE - Irlanda 363
SG - Singapore 226
GB - Regno Unito 222
FR - Francia 220
FI - Finlandia 188
RU - Federazione Russa 170
TR - Turchia 160
IN - India 139
PL - Polonia 62
BE - Belgio 39
IR - Iran 26
AU - Australia 25
HK - Hong Kong 25
EU - Europa 22
JP - Giappone 22
CA - Canada 16
RO - Romania 15
CH - Svizzera 12
NL - Olanda 12
CI - Costa d'Avorio 10
CZ - Repubblica Ceca 10
PT - Portogallo 10
BR - Brasile 8
IL - Israele 8
ES - Italia 7
HU - Ungheria 6
BZ - Belize 5
DK - Danimarca 5
ID - Indonesia 5
MK - Macedonia 5
MX - Messico 5
CL - Cile 4
EE - Estonia 4
KR - Corea 4
NZ - Nuova Zelanda 4
PE - Perù 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EG - Egitto 3
GR - Grecia 3
MY - Malesia 3
NG - Nigeria 3
PA - Panama 3
VN - Vietnam 3
AT - Austria 2
NO - Norvegia 2
PR - Porto Rico 2
SC - Seychelles 2
SD - Sudan 2
TH - Thailandia 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
DJ - Gibuti 1
GE - Georgia 1
HR - Croazia 1
KW - Kuwait 1
MA - Marocco 1
MC - Monaco 1
MD - Moldavia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 14.575
Salva come PNG Salva come JPEG
Città #
Chandler 1.337
Ashburn 439
Jacksonville 405
Dublin 361
San Mateo 332
Nanjing 232
Ann Arbor 223
Wilmington 194
Nürnberg 180
Boston 176
Cattolica 151
Izmir 151
Houston 149
New York 147
Singapore 140
Dearborn 139
Princeton 122
Woodbridge 119
Moscow 108
Munich 104
Beijing 101
Marseille 98
Nanchang 98
Rome 82
Milan 80
Boardman 73
Seattle 70
Redwood City 67
Lawrence 66
Redmond 63
Chicago 60
Fairfield 57
Hebei 55
Kraków 55
Tianjin 52
Helsinki 48
Mountain View 46
Bremen 45
Shenyang 43
Kunming 40
Brussels 39
University Park 39
Jiaxing 36
Norwalk 36
Zhengzhou 36
Changsha 35
Hangzhou 31
San Jose 30
Augusta 28
Fremont 28
Los Angeles 28
Jinan 25
Hong Kong 24
Washington 24
Cambridge 22
Guangzhou 21
Andover 20
Falls Church 20
Pune 20
Simi Valley 20
Lancaster 17
Saint Petersburg 17
Leawood 15
Ningbo 14
Lanzhou 13
London 13
San Diego 13
Taizhou 13
Detroit 12
Abidjan 10
Indiana 10
Kish 10
Brno 9
Changchun 9
Buffalo 8
Campagna 8
Edinburgh 8
Shanghai 8
Amsterdam 7
Atlanta 7
Busto Arsizio 7
Hefei 7
Monmouth Junction 7
Phoenix 7
Provo 7
San Francisco 7
Tappahannock 7
Warsaw 7
Zurich 7
Chengdu 6
Las Vegas 6
Portland 6
Albuquerque 5
Belize City 5
Chiswick 5
Esslingen am Neckar 5
Paris 5
Stockholm 5
Tokyo 5
Toronto 5
Totale 7.412
Salva come PNG Salva come JPEG
Nome #
Gastrointestinal amyloidosis: a case of chronic diarrhoea. 269
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 254
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 204
13C-methionine breath tests for mitochondrial liver function assessment. 201
A phase II study of sunitinib in advanced hepatocellular carcinoma 200
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 178
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 174
-Hepatic steatosis and vascular disease 166
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 158
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 152
134C-breath tests in the study of mitochondrial liver function 147
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 145
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 144
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 141
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 140
Effect of sildenafil on diabetic gastropathy. 136
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 135
13C-breath tests in the study of microsomial liver function 135
recurrent acute hepatitis associated with use of cetrizine 124
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 124
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 123
Epicardial fat thickness correlates with body fat stores, insulin resistance and alanine aminotransferase in patients affected by nonalcoholic steatohepatitis (NASH) 122
13C-methionine breath tests for mitochondrial liver function assessment 122
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 118
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 115
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 114
Vanishing-recurrent benign liver lesions 111
13C-breath tests in the study of mitochondrial liver function 110
Potential use of liver function breath tests in the clinical practice. 110
Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? 109
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 107
[The treatment of hepatocellular carcinoma: an update] 104
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 104
Faecal calprotectin concentrations in untreated coeliac patients 103
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 101
Hepatitis C in the elderly: A multicentre cross-sectional study by the Italian Association for the Study of the Liver 101
gastroesophageal reflux disease: facts and uncertaines 99
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 99
Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). 98
Tromboembolism and breast cancer: the hidden risk for patient and physician 98
-Fatty liver and drugs 97
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 97
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 96
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 95
Liver resection for hepatocellular carcinoma in patient with situs inversus viscerum 95
Cryoglobulinemia: a true internistic disease? 94
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 94
A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease 94
Bone metastasis in hepatocellular carcinoma. A report of five cases and a review of the literature. 93
FAECAL CALPROTECTIN CONCENTRATIONS IN UNTREATED CELIAC PATIENTS 90
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 88
Comment on "the role of endoscopic ultrasound in the evaluation of chronic mesenteric ischaemia" 88
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 88
Liver transplantation in patients with alcoholic liver disease: A retrospective study 87
Liver metastases of endocrine tumour associated with multiple endocrine neoplasia type 1: a sustained response to interferon therapy or a peculiar benign course? 86
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 86
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic Fatty liver disease 83
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 83
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. 82
Severe giant cell arteritis associated with essential thrombocythaemia. 82
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study 82
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 82
-Nonalcoholic fatty liver disease: defining a common problem 81
Antipyrine clearance in chronic and neoplastic liver diseases: a study of 518 patients. 81
Alcoholic and nonalcoholic forms of fatty liver disease. 80
Advanced colon cancer: staging and prognosis by CEA test 79
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial 78
Braised liver with herbs: the risks of naturopathic hepatoprotection. 78
Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target 78
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 77
Severe acute hepatitis after resumption of interferon-Beta therapy for multiple sclerosis: a word of caution. 76
Low-dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms. 76
Gender affects 13C-ketoisocaproic acid breath test 75
A giant calcified hepatic mass 75
Is coeliac disease a confounding factor in the diagnosis of NASH? 73
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 73
Review article: breath testing for human liver function assessment. 73
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People 73
Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners. 72
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 72
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 72
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 71
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 71
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 70
Impairment of recent thymic emigrants in HCV infection. 68
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 68
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 68
Drug-induced hepatitis 67
Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH) 67
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 67
Acute fatty liver after malaria prophylaxis with mefloquine 66
Ventricular thrombosis during sorafenib therapy for advanced hepatocellular carcinoma 66
Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind 66
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 66
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 65
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 64
Focus on fatty liver in clinical practice 63
"tear-drop shaped" HCC 63
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 63
NON ALCOHOLIC STEATOHEPATITIS (NASH) INDUCED BY CARBAMAZEPINE AND VARIEGATE PORPHYRIA 62
Totale 10.160
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.320
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.320
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.954 408 95 91 69 129 165 231 108 117 173 178 190
2020/20211.518 89 166 77 172 190 63 159 32 194 71 273 32
2021/20221.743 69 162 46 176 122 43 29 285 62 87 318 344
2022/20233.647 484 483 282 537 266 438 157 333 422 46 145 54
2023/20241.793 119 532 70 83 72 260 113 64 23 69 158 230
2024/202576 76 0 0 0 0 0 0 0 0 0 0 0
Totale 14.782